Literature DB >> 27482259

Thirty-Year Trends in Mortality from Cerebrovascular Diseases in Korea.

Seung Won Lee1, Hyeon Chang Kim2, Hye Sun Lee3, Il Suh4.   

Abstract

BACKGROUND AND OBJECTIVES: Cerebrovascular disease is a leading cause of mortality and morbidity in Korea. Understanding of cerebrovascular disease mortality trends is important to reduce the health burden from cerebrovascular diseases. We examined the changing pattern of mortality related to cerebrovascular disease in Korea over 30 years from 1983 to 2012. SUBJECTS AND METHODS: Numbers of deaths from cerebrovascular disease, hemorrhagic stroke, and cerebral infarction were obtained from the national Cause of Death Statistics. Crude and age-adjusted mortality rates were calculated for men and women for each year. Penalized B-spline methods, which reduce bias and variability in curve fitting, were used to identify the trends of 30-year mortality and identify the year of highest mortality.
RESULTS: During the 30 years, cerebrovascular disease mortality has markedly declined. The age-adjusted cerebrovascular disease mortality rate has decreased by 78% in men and by 68% in women. In the case of hemorrhagic stroke, crude mortality peaked in 2001 but age-adjusted mortality peaked in 1994. Between 1994 and 2012, age-adjusted mortality from hemorrhagic stroke has decreased by 68% in men and 59% in women. In the case of cerebral infarction, crude and age-adjusted mortality rates steeply increased until 2004 and 2003, respectively, and both rates decreased rapidly thereafter.
CONCLUSION: Cerebrovascular disease mortality rate has significantly decreased over the last 30 years in Korea, but remains a health burden. The prevalence of major cardiovascular risk factors are still highly prevalent in Korea.

Entities:  

Keywords:  Cerebrovascular disorders; Korea; Mortality; Stroke; Trends

Year:  2016        PMID: 27482259      PMCID: PMC4965429          DOI: 10.4070/kcj.2016.46.4.507

Source DB:  PubMed          Journal:  Korean Circ J        ISSN: 1738-5520            Impact factor:   3.243


Introduction

Cerebrovascular disease mortality ranks as the second most common cause of death around the world,1) but, in Korea, cerebrovascular disease is the leading cause of death among single -organ diseases.2)3) Every year approximately 105000 people experience a new or recurrent stroke and more than 26000 people die.2) Fortunately, there have been great improvements in the management of stroke over the last decades. Among the Organization for Economic Cooperation and Development (OECD) member countries, Korea recorded the lowest in-hospital, 30-day case-fatality rate for ischemic stroke and the third lowest rate for hemorrhagic stroke in 2009.2)4) Understanding cerebrovascular disease mortality trends is important to reduce the health burden. Mortality trends of cerebrovascular diseases have been reported in many countries including Korea.5)6)7) However, there are only a few studies reporting long-term trends in mortality from cerebrovascular diseases in the Korean population. Thus, we examined the 30-year changing pattern of cerebrovascular disease mortality in Korea to further understand and quantify recent trends in mortality by analyzing the Cause of Death statistics from Statistics Korea.

Subjects and Methods

Annual mortality data were obtained from the Korean Statistical Information Service managed by Statistics Korea (former the Korea National Statistical Office). Mortality statistics with cause of death information have been available since 1983. Causes of death were coded according to the International Classification of Disease, 10th Revision. For the purpose of this study, deaths from cerebrovascular disease (I60-69) were further classified into hemorrhagic stroke (I60-62), cerebral infarction (I63), unspecified stroke (I64), and other cerebrovascular diseases (I65-69). Hemorrhagic stroke included subarachnoid hemorrhage (I60), intracerebral hemorrhage (I61), and other nontraumatic intracranial hemorrhage (I62). Mortality rates from total heart diseases (I00-13 and I20-51) and ischemic heart disease (I20-25) were previously reported.8) Crude and age-adjusted mortalities were calculated only for cerebrovascular disease, hemorrhagic stroke, and cerebrovascular disease, because reported numbers of deaths from unspecified stroke and other cerebrovascular diseases showed great fluctuation in the 1990s and early 2000s, probably due to changes in classifying causes of death. We calculated age-adjusted mortality through a direct standardization method using the age distribution of the Korean population in 2000 as the standard population. We analyzed data using 10-year age intervals and the same population structure for standardization in men and women to compare mortality by sex. We also presented penalized B-Splines to explore the non-linear pattern of the crude death rate and age-adjusted death rate per 100000 over time in years. Penalized regression methods are used to quantify the notion of roughness of a curve through a suitable penalty function and the necessary compromise between bias and variability in curve fitting can be explicit in estimation of the problem.9)

Results

Numbers of deaths from cerebrovascular disease

Table 1 and Fig. 1 show the number of deaths from cerebrovascular diseases for each year. The absolute number of deaths from cerebrovascular disease did not change much between 1983 and 1990, but it increased rapidly in the early 1990s then stayed high until 2002. However, after 2002, the number of deaths from cerebrovascular disease has consistently declined. The number of deaths from cerebrovascular disease was 26922 in 1983, peaked at 37131 in 1994, and decreased to 25447 by 2013. Number of deaths from hemorrhagic stroke peaked in 2002, while deaths from cerebral infarction reached its peak in 2004. In 1983, deaths from hemorrhagic stroke (n=5549) were almost 8 times more common than deaths from cerebral infarction (n=703). However, since 2003, cerebral infarction has been the most common cause of death among cerebrovascular diseases. The number of deaths from unspecified stroke increased steeply between 1996 and 1998, but it rapidly decreased until recently since 1998.
Table 1

Numbers of deaths from cerebrovascular diseases

YearCerebrovascular disease (I60-69)Hemorrhagic stroke (I60-62)Cerebral infarction (I63)Unspecified stroke (I64)Other cerebrovascular disease (I65-69)
TotalMenWomenTotalMenWomenTotalMenWomenTotalMenWomenTotalMenWomen
198326922147491217355493190235970338132210254571345411041654654951
19842691914551123685623316024637584163429736529844381080256775125
1985278831504712836623534842751107057949110117547946381046155054956
19862696614513124536371355728141172626546994153474594948249834499
19872598413693122916230337128591181612569957050874483900346234380
19882623413722125126679360630731238614624968050644616863744384199
19892650513848126577230378834421533820713957449474627816842933875
19902703913902131376909359033191681898783980850814727864143334308
199127152136801347275353908362718971035862873942984441898144394542
19923223615642165948969448644832495129711989125445846671164754016246
19933521616943182739802481749852803143313709450460748431316160867075
1994371311779319338100225001502131491644150510502499555071345861537305
199536416173001911698684822504637671915185210337498853491244455756869
199634590165081808210052490651464111209020219788466151271063948515788
19973396616467174999946491750294449229921501156555536012800636984308
199834464165551790910197504551524451227521761720180379164261511981417
199934374163901798410653520054534944249824461615174268725262612661360
200034754165371821710695524054557357349638611332462247100337815771801
200135295170351826010766527054967987383941481121954095810532325172806
200237067175111955610839531855211002746865341912642124914707532953780
200336396171761922010751526554861147952576222720233113891696433433621
20043400316166178379874483750371179354306363576826693099656832303338
20053119514886163099098440546931066449885676422619902236720735033704
20062995114460154918526415043761017747675410400519602045724335833660
20072927713941153368030396540651069349045789294413911553761036813929
2008279321355314379773338773856958244445138256812831285804939494100
2009258361264813188720735863621847540104465211310471066804140054036
20102651412865136497503371737868164379143731908943965893944144525
20112540412185132197112351835947860352043401653828825877943194460
20122574412380133646767333734307490346940211554706848993348685065
20132544712096133516710331833927558346840901387629758979246815111
Fig. 1

Number of deaths from cerebrovascular disease.

Crude and age-adjusted mortality from cerebrovascular disease

The crude mortality rate from cerebrovascular disease showed fluctuating patterns until 2002, but thereafter it decreased. In the 1980s, the crude mortality rate for men was higher than for women, but the gender difference gradually decreased and has reversed since 1991. The crude mortality rate from cerebrovascular disease in 1983 was 73.3 per 100000 in men and 61.5 per 100000 women. In 2012, the crude mortality rate per 100000 was 49.2 for men and 53.1 for women. After the highest crude mortality rate in 1994, there were 33% and 14% mortality decreases in men and women, respectively, until 2012. Age-adjusted mortality rates from cerebrovascular disease has decreased too, until recently, but the rate has been always higher in men than in women. In 1983, the age-adjusted mortality rate for men was about 2 times higher than for women (124.3 vs. 68.1 per 100000). But the sex difference has gradually reduced to 28.7 per 100000 men and 17.2 per 100000 women in 2012 (Fig. 2).
Fig. 2

Crude and age-adjusted mortality from cerebrovascular diseases fitted by Penalized B-Splines method. (A) Crude mortality from cerebrovascular diseases in men. (B) Crude mortality from cerebrovascular diseases in women. (C) Age-adjusted mortality from cerebrovascular diseases in men. (D) Age-adjusted mortality from cerebrovascular diseases in women.

Crude and age-adjusted mortality from hemorrhagic stroke

Crude mortality rate from hemorrhagic stroke showed upward trends between 1983 and 2001. But, after 2001, the rate has rapidly decreased. The crude mortality rate for men was higher than for women until 1991, but thereafter the rate for women was higher than men. In 1983, the crude mortality rate from hemorrhagic stroke per 100000 was 15.8 for men and 11.9 for women, but the corresponding rate was 13.3 for men and 13.7 for women in 2012. After the highest mortality rate in 2001, there was about a 39.8% decrease in men and 41.5% decrease in women until 2012. Age-adjusted hemorrhagic stroke mortality rate peaked in 1994, then the rate decreased in both men and women. Unlike crude mortality, the age-adjusted mortality rate has been consistently higher in men than in women. The age-adjusted hemorrhagic stroke mortality rate per 100000 was 24.4 for men and 14.2 for women in 1983. However, the corresponding rate decreased to 8.6 for men and 5.8 for women by 2012. After the highest age-adjusted mortality rate in 1994, there was a 68.1% decrease in men and a 41.5% decrease in women until 2012 (Fig. 3). It is also notable that crude hemorrhagic stroke mortality peaked in 2001, but the age-adjusted mortality peaked much earlier in 1994.
Fig. 3

Crude and age-adjusted mortality from hemorrhagic stroke fitted by Penalized B-Splines method. (A) Crude mortality from hemorrhagic stroke in men. (B) Crude mortality from hemorrhagic stroke in women. (C) Age-adjusted mortality from hemorrhagic stroke in men. (D) Age-adjusted mortality from hemorrhagic stroke in women.

Crude and age-adjusted mortality rates from cerebral infarction

Crude mortality rate from cerebral infarction increased until 2004. But, thereafter, the rate has rapidly decreased. Crude mortality rate per 100000 was 1.9 for men and 1.6 for women in 1983, which increased to 22.3 in men and 26.3 for women in 2004, then decreased to 13.8 for men and 16 for women by 2012. After the highest age-adjusted mortality rate in 2004, there was a 30.7% decrease in men and 32.2% decrease in women. Age-adjusted cerebral infarction mortality rates peaked in 2003. Unlike crude mortality, the age-adjusted cerebral infarction mortality rate has been consistently higher in men than in women. After the highest age-adjusted mortality in 2003, there was about 61.8% decrease in men and 65.6% decrease in women (Fig. 4). Figures without penalized regression splines for cerebrovascular diseases are provided as supplemental data (Supplementary Figs. 1 to 3 in the online-only Data Supplement).
Fig. 4

Crude and age-adjusted mortality from cerebral infarction fitted by Penalized B-Splines method. (A) Crude mortality from cerebral infarction in men. (B) Crude mortality from cerebral infarction in women. (C) Age-adjusted mortality from cerebral infarction in men. (D) Age-adjusted mortality from cerebral infarction in women.

Discussion

Our study reports the death rate of major cerebrovascular diseases in the Korean population and their trends over the last 30 years. The age-standardized mortality rate from cerebrovascular diseases has significantly decreased since 1983 in Korea and the decline in mortality from cerebrovascular diseases was more prominent in men than women. Over the last three decades, the age-adjusted mortality rate from cerebrovascular diseases decreased, but temporarily increased between 1991 and 1993. This fluctuation might be due to changes of classification of the Cause of Death Statistics in Korea. During the same time period, deaths from hypertensive disease (I10-I15) significantly decreased.8) In most developed countries, cerebrovascular disease had been among the leading causes of death in the past, but it has decreased in recent decades.10)11) In particular, Australia, New Zealand, and the UK showed a continuous decline in cerebrovascular disease mortality since 1950. The United States showed a steep declining trend since the 1970s and the trend was more prominent in men than women.10)11)12) Among Asian countries, Japan had the highest cerebrovascular disease mortality in the 1950s (433 per 100000 in men in 1957), but the rate significantly decreased to less than 100 per 100000 by 2004.6)10) Recent studies reported that the stroke mortality rate of Korea was double that of Japan in the beginning of the 2000s,10) although both Japan and Korea showed decreasing mortality trends for stroke at that time.13) A number of studies reported the accelerated decline in stroke mortality during the late 1970s and the early 1980s. Among them, some earlier studies reported declining trends in the stroke incidence rate as well as stroke fatalities during the 1970s,14)15) suggesting that the effect of stroke incidence rate on stroke mortality.14) However, there was no significant association between stroke mortality and stroke incidence in Sweden.15) This study reported that a decline of mortality from stroke may be due to a decline of smoking and blood pressure (BP) together with an increase in the use of anti-hypertensive treatments rather than changes of stroke incidence.15) Accordingly, it may be because acute stroke events have become less severe and the survival rate of stroke patients is increasing. The successful control of risk factors may have contributed to declining incidence and fatality of stroke, which may lead to the decreasing trends of stroke mortality.16)17) In most populations, hypertension is the most attributable factor for cerebrovascular disease.18)19)20) In a previous study analyzing data from 1998-2011 available in the Korea National Health Nutrition Examination Survey (KNHANES),21) the age-adjusted prevalence of hypertension decreased by 0.2 to 0.3 percent annually. The study reported that mean systolic BP level decreased by 8 mmHg in men and by 10 mmHg in women during this period which suggested that decreasing BP was largely due to lowered BP levels among patients with diagnosed hypertension.21) The improved BP control might contribute to the remarkable decrease in stroke mortality in Korea. In another systematic review of data from Korean or other populations, the attributable risk of hypertension for ischemic stroke was 19.9 to 30.5% in men and 17.1 to 26.6% in women.22) At ages 40 to 69, usual BP is directly related to stoke mortality in a meta-analysis of clinical trials.23) On the other hand, a few studies were unconvincing that improvement in control of hypertension resulted in a decline of mortality from stroke.24) However, according to a meta-analysis of clinical trials in 1992, anti-hypertensive treatment reduced fatal strokes by 33% and cardiovascular mortality by 22%.25)26) The use of cholesterol-lowering medications also decreased stroke risk and mortality in observational studies and clinical trials.27)28) Improved acute stroke management might also contribute to the mortality decline.7) Between 1998 and 2002, the prevalence of hypertension decreased, whereas the prevalence of hypercholesterolemia significantly increased in both sexes.4) Smoking rate decreased only in men, whereas the prevalence of diabetes did not change over time. Another study reported epidemiologic trends of ischemic stroke between 2002 and 2010, by analyzing data from the Korean Stroke Registry.29) Patient's age steadily increased, while prevalence of risk factors such as hypertension, diabetes, and smoking declined. Although cerebrovascular disease mortality rate has decreased over the last 30 years, cerebrovascular disease still remains a great burden to society and is a major cardiovascular risk factor prevalent among Koreans. To further reduce the burden of cerebrovascular disease, we need to monitor the trends of mortality from cerebrovascular disease and its subcategories, because management and prevention strategies for different stroke types vary. The major strength of the present study is that it analyzed nationwide mortality data covering 30 years in the Korean population. But, there are also several limitations to be discussed. First, validity of cause of death can be debated. The Statistics Korea report annually the Cause of Death Statistics, and the database are primarily based on the death certificates. A previous study retrospectively compared the Cause of Death Statistics with hospital medical records, and reported the overall accuracy of causes of death as 91.9%.30) Second, there are still a significant number of deaths recorded without underlying causes in the Death Statistics. In 2012, 9.4% of deaths were classified as unknown, although the deaths by unknown causes are decreasing. Thus there is a possibility of underestimation of mortality from cerebrovascular disease. Third, the reported number of cerebrovascular deaths can be influenced by the health care system. Over the last decades, Korea experienced marked improvement in medical service accessibility and health care technologies. These changes might affect the reported number of cerebrovascular diseases. Lastly, there is no available nationwide data on the incidence of cerebrovascular disease, so we cannot explore the underlying causes of changing mortality trends. In conclusion, cerebrovascular disease mortality has significantly decreased over the last 30 years, but remains a great health burden and the prevalence of major for cardiovascular risk factors are still highly prevalent in Korea. We need to continuously monitor the trends of mortality from cerebrovascular disease and its subcategories to further reduce cerebrovascular disease burdens.
  27 in total

1.  A meta-analysis of outcome trials in elderly hypertensives.

Authors:  L Thijs; R Fagard; P Lijnen; J Staessen; R Van Hoof; A Amery
Journal:  J Hypertens       Date:  1992-10       Impact factor: 4.844

2.  Burden of disease in Korea during 2000-10.

Authors:  K S Lee; J H Park
Journal:  J Public Health (Oxf)       Date:  2013-06-11       Impact factor: 2.341

3.  The continuing decline in the incidence of stroke.

Authors:  W M Garraway; J P Whisnant; I Drury
Journal:  Mayo Clin Proc       Date:  1983-08       Impact factor: 7.616

4.  Risk factors for ischaemic and intracerebral haemorrhagic stroke in 22 countries (the INTERSTROKE study): a case-control study.

Authors:  Martin J O'Donnell; Denis Xavier; Lisheng Liu; Hongye Zhang; Siu Lim Chin; Purnima Rao-Melacini; Sumathy Rangarajan; Shofiqul Islam; Prem Pais; Matthew J McQueen; Charles Mondo; Albertino Damasceno; Patricio Lopez-Jaramillo; Graeme J Hankey; Antonio L Dans; Khalid Yusoff; Thomas Truelsen; Hans-Christoph Diener; Ralph L Sacco; Danuta Ryglewicz; Anna Czlonkowska; Christian Weimar; Xingyu Wang; Salim Yusuf
Journal:  Lancet       Date:  2010-06-17       Impact factor: 79.321

Review 5.  Treatment of hypertension in the elderly.

Authors:  A F Lever; L E Ramsay
Journal:  J Hypertens       Date:  1995-06       Impact factor: 4.844

6.  Trends in the prevalence of major cardiovascular disease risk factors among Korean adults: results from the Korea National Health and Nutrition Examination Survey, 1998-2012.

Authors:  Hyun Ja Kim; Yuna Kim; Yumi Cho; Byungyool Jun; Kyung Won Oh
Journal:  Int J Cardiol       Date:  2014-03-28       Impact factor: 4.164

Review 7.  Framingham study insights into hypertensive risk of cardiovascular disease.

Authors:  W B Kannel
Journal:  Hypertens Res       Date:  1995-09       Impact factor: 3.872

8.  Stroke incidence rates were unchanged, while fatality rates declined, during 1971-1987 in Göteborg, Sweden.

Authors:  P Harmsen; A Tsipogianni; L Wilhelmsen
Journal:  Stroke       Date:  1992-10       Impact factor: 7.914

9.  Thirty-year trends in mortality from cardiovascular diseases in Korea.

Authors:  Seung Won Lee; Hyeon Chang Kim; Hye Sun Lee; Il Suh
Journal:  Korean Circ J       Date:  2015-05-27       Impact factor: 3.243

Review 10.  Stroke statistics in Korea: part I. Epidemiology and risk factors: a report from the korean stroke society and clinical research center for stroke.

Authors:  Keun-Sik Hong; Oh Young Bang; Dong-Wha Kang; Kyung-Ho Yu; Hee-Joon Bae; Jin Soo Lee; Ji Hoe Heo; Sun U Kwon; Chang Wan Oh; Byung-Chul Lee; Jong S Kim; Byung-Woo Yoon
Journal:  J Stroke       Date:  2013-01-31       Impact factor: 6.967

View more
  16 in total

1.  Current State of Cardiovascular Research in Korea.

Authors:  Jae Il Shin; Jaewon Oh; Hyeon Chang Kim; Donghoon Choi; Young-Sup Yoon
Journal:  Circ Res       Date:  2019-12-05       Impact factor: 17.367

2.  Trends in Mortality from Hemorrhagic Stroke in Korea from 2012 to 2020.

Authors:  Kwang-Chun Cho; Hasung Kim; Sang Hyun Suh
Journal:  Neurointervention       Date:  2022-06-23

3.  Public Awareness of Stroke and Its Predicting Factors in Korea: a National Public Telephone Survey, 2012 and 2014.

Authors:  Gyung Jae Oh; Jiyoung Moon; Yu Mi Lee; Hyeung Keun Park; Ki Soo Park; Yong Woon Yun; Gilwon Kang; Byoung Gwon Kim; Jae Hee Seo; Heeyoung Lee; Won Kyung Lee; Kun Sei Lee; Hee Sook Kim; Young Hoon Lee
Journal:  J Korean Med Sci       Date:  2016-11       Impact factor: 2.153

4.  Effect of methanol extract of Salviae miltiorrhizae Radix in high-fat diet-induced hyperlipidemic mice.

Authors:  Chiyeon Lim; Sehyun Lim; Byoungho Lee; Buyeo Kim; Suin Cho
Journal:  Chin Med       Date:  2017-10-13       Impact factor: 5.455

Review 5.  Prevalence and Clinical Characteristics of Dyslipidemia in Koreans.

Authors:  Jee Sun Jeong; Hyuk Sang Kwon
Journal:  Endocrinol Metab (Seoul)       Date:  2017-03

6.  Cardiovascular and Metabolic Diseases Etiology Research Center (CMERC) cohort: study protocol and results of the first 3 years of enrollment.

Authors:  Jee-Seon Shim; Bo Mi Song; Jung Hyun Lee; Seung Won Lee; Ji Hye Park; Dong Phil Choi; Myung Ha Lee; Kyoung Hwa Ha; Dae Jung Kim; Sungha Park; Won-Woo Lee; Hyeon Chang Kim
Journal:  Epidemiol Health       Date:  2017-04-01

7.  Prevalence, Awareness, Treatment, and Control of Hypertension in Korea.

Authors:  Si-Hyuck Kang; Sun-Hwa Kim; Jun Hwan Cho; Chang-Hwan Yoon; Seung-Sik Hwang; Hae-Young Lee; Tae-Jin Youn; In-Ho Chae; Cheol-Ho Kim
Journal:  Sci Rep       Date:  2019-07-29       Impact factor: 4.379

8.  Risk of ischemic stroke in metabolically healthy obesity: A nationwide population-based study.

Authors:  Hyun-Jung Lee; Eue-Keun Choi; Seung-Hwan Lee; Yong-Jin Kim; Kyung-Do Han; Seil Oh
Journal:  PLoS One       Date:  2018-03-30       Impact factor: 3.240

9.  Gender-specific factors related to suicidal ideation among community-dwelling stroke survivors: The 2013 Korean Community Health Survey.

Authors:  Mina Kim; Young-Hoon Lee
Journal:  PLoS One       Date:  2018-08-02       Impact factor: 3.240

10.  Effect of Ephedrae Herba methanol extract on high-fat diet-induced hyperlipidaemic mice.

Authors:  Se-Eun Lee; Chiyeon Lim; Sehyun Lim; Byoungho Lee; Suin Cho
Journal:  Pharm Biol       Date:  2019-12       Impact factor: 3.503

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.